- Home
- RGP vs KALV Comparison
RGP vs KALV Comparison
Compare RGP & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGP
- KALV
- Stock Information
- Founded
- RGP 1996
- KALV N/A
- Country
- RGP United States
- KALV United States
- Employees
- RGP N/A
- KALV N/A
- Industry
- RGP Business Services
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- RGP Consumer Discretionary
- KALV Health Care
- Exchange
- RGP Nasdaq
- KALV Nasdaq
- Market Cap
- RGP 303.9M
- KALV 362.2M
- IPO Year
- RGP 2006
- KALV N/A
- Fundamental
- Price
- RGP $8.69
- KALV $8.75
- Analyst Decision
- RGP Hold
- KALV Strong Buy
- Analyst Count
- RGP 3
- KALV 7
- Target Price
- RGP $13.00
- KALV $27.00
- AVG Volume (30 Days)
- RGP 453.8K
- KALV 319.9K
- Earning Date
- RGP 01-02-2025
- KALV 03-10-2025
- Dividend Yield
- RGP 6.56%
- KALV N/A
- EPS Growth
- RGP N/A
- KALV N/A
- EPS
- RGP N/A
- KALV N/A
- Revenue
- RGP $582,058,000.00
- KALV N/A
- Revenue This Year
- RGP N/A
- KALV N/A
- Revenue Next Year
- RGP $16.91
- KALV N/A
- P/E Ratio
- RGP N/A
- KALV N/A
- Revenue Growth
- RGP N/A
- KALV N/A
- 52 Week Low
- RGP $7.90
- KALV $7.30
- 52 Week High
- RGP $14.29
- KALV $16.88
- Technical
- Relative Strength Index (RSI)
- RGP 55.05
- KALV 51.87
- Support Level
- RGP $8.31
- KALV $7.30
- Resistance Level
- RGP $8.90
- KALV $9.16
- Average True Range (ATR)
- RGP 0.38
- KALV 0.41
- MACD
- RGP 0.00
- KALV 0.07
- Stochastic Oscillator
- RGP 29.05
- KALV 78.17
About RGP Resources Connection Inc.
Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.